Physician profile
Diego Escobar
NPI 1881622181
$3,313.83
in general payments reported to CMS, 2019-2025
11 companies · $1,556 in 2025
The $1,556 reported for 2025 was more than what 88% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $246 · 2024: $1,512 · 2025: $1,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,313.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,527.39 | 2023-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Ets Wound Care LLC | $574.98 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Organogenesis INC. | $489.70 | 2024-2025 | Apligraf, Nushield, Puraply Wound Matrix |
| Cashflow Solutions, LLC | $178.04 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kerecis Limited | $125.80 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Hydrofera LLC | $114.51 | 2024 | Hydrofera Blue |
| Solventum Corporation | $94.56 | 2024-2025 | Activ.A.C., Snap |
| Mimedx Group, INC. | $92.51 | 2024-2025 | |
| Urgo Medical North America, LLC | $56.06 | 2024-2025 | Urgoclean Ag |
| Integra Lifesciences Corporation | $45.02 | 2023-2024 | Tcc-Ez |
| Kci USA, INC. | $15.26 | 2023 | Promogran Prisma, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Escobar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.